Fem-1 Homolog B (FEM1B) Peptide
-
- Target See all FEM1B products
- FEM1B (Fem-1 Homolog B (FEM1B))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-FEM1B antibody (Catalog #: ARP53702_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- FEM1B (Fem-1 Homolog B (FEM1B))
- Background
-
FEM1B is a component of an E3 ubiquitin-protein ligase complex, in which it may act as a substrate recognition subunit. It involved in apoptosis by acting as a death receptor-associated protein that mediates apoptosis. FEM1B also involved in glucose homeostasis in pancreatic islet.
Alias Symbols: DKFZp451E0710, FIAA, F1A-ALPHA
Protein Interaction Partner: APAF1,FAS,FEM1B,KIAA0319,COPS6
Protein Size: 627 - Molecular Weight
- 69 kDa
- Gene ID
- 10116
- NCBI Accession
- NM_015322, NP_056137
- UniProt
- Q9UK73
-